1942.HK

MOG Holdings Limited 1942.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1942.HK 1011.HK 1652.HK 1612.HK 3737.HK 2297.HK 2325.HK 1120.HK 2289.HK 0876.HK
6M 13.89 % 118.67 % 166.67 % 134.21 % -28.89 % 52.17 % -61.81 % -15.63 % -29.22 % 100.00 %
YTD -59.41 % 203.70 % -10.00 % 122.50 % -35.35 % 75.00 % -84.27 % -10.00 % -44.33 % 132.00 %
1Y -68.94 % 107.59 % -26.53 % 106.98 % -28.09 % 78.34 % -86.59 % 2.53 % -32.47 % 100.00 %
3Y -87.03 % 925.00 % -25.77 % 119.75 % -15.79 % -89.63 % -91.81 % 12.50 % -24.31 % -36.96 %
5Y -50.00 % -29.91 % -82.04 % -57.62 % -59.49 % -94.70 % -86.12 % 3.85 % 20.04 % -53.23 %
10Y -18.00 % -95.88 % -71.65 % -5.32 % -73.33 % -94.70 % -86.12 % -71.88 % -31.88 % -88.40 %
From the beginning -18.00 % -25.45 % -71.65 % -5.32 % -73.22 % -94.70 % -86.12 % -13.83 % -31.88 % -22.02 %

Dividend

MOG Holdings Limited

China NT Pharma Group Company Limited

Fusen Pharmaceutical Company Limited

Vincent Medical Holdings Limited

Zhongzhi Pharmaceutical Holdings Limited

Yunkang Group Limited

Arts Optical International Holdings Limited

Charmacy Pharmaceutical Co., Ltd.

Kaisa Health Group Holdings Limited